Table 1. The initial panel of candidate tumor dependent pairs for lung adenocarcinoma (LADC), with fractions of the four differentially expressed patterns by the threshold 1.5-fold, screened from 668 collected synthetic lethal (SL) gene pairs.
Tumor dependent pairs | Fractions of SL gene pairs computed from 83 Asian LADC versus non-cancerous tissues that were expressed 1.5-fold or higher | ||||||
---|---|---|---|---|---|---|---|
Gene 1 | Gene 2 | (up, up) pattern | (up, down) pattern | (down, up) pattern | (down, down) pattern | Permutation p-value |
q-value |
FEN1 | RAD54B | 0.31a | 0.01 | 0.00 | 0.01 | 0.0001 | 0.0043 |
BRCA1 | PARP1 | 0.18 | 0.00 | 0.00 | 0.00 | 0.0001 | 0.0043 |
MSH2 | POLB | 0.14 | 0.01 | 0.02 | 0.00 | 0.0006 | 0.0156 |
BCR | WNT5A | 0.11 | 0.01 | 0.01 | 0.00 | 0.0023 | 0.0473 |
BRCA2 | PARP1 | 0.11 | 0.00 | 0.00 | 0.00 | 0.0022 | 0.0473 |
TP53 | SGK2 | 0.06 | 0.00 | 0.00 | 0.00 | 0.0273 | 0.2367 |
MYC | AURKB | 0.05 | 0.00 | 0.23 | 0.00 | 0.0001 | 0.0043 |
ABL1 | WNT5A | 0.05 | 0.00 | 0.06 | 0.07 | 0.3871 | 0.5180 |
TP53 | PAK3 | 0.02 | 0.06 | 0.02 | 0.01 | 0.2279 | 0.4757 |
EGFR | SLEGFRb | 0.01~0.18 | 0.00 | 0.00 | 0.00 | 0.0001~0.4940 | 0.0043~0.5180 |
EGFR | SLEGFRc | 0.00 | 0.01~0.20 | 0.00 | 0.00 | 0.0001~0.5084 | 0.0043~0.5180 |
KRAS | SLKRASd | 0.01~0.07 | 0.00 | 0.00 | 0.00 | 0.0143~0.7506 | 0.1642~0.7506 |
KRAS | SLKRASe | 0.00 | 0.01~0.07 | 0.00 | 0.00 | 0.0298~0.7410 | 0.2367~0.7448 |
The four fractions were computed from gene pairs that were 1.5-fold differentially expressed, thus they might not sum up to 100%.
22 verified EGFR SL pairs were identified in the (up, up) pattern.
30 verified EGFR SL pairs were identified in the (up, down) pattern.
168 verified KRAS SL pairs were identified in the (up, up) pattern.
121 verified KRAS SL pairs were identified in the (up, down) pattern.
The p-value for the highest fraction of the four patterns was computed by permutation test with 10,000 repeats, and the false discovery rate was estimated by q-value.